Takara Bio to acquire US WaferGen Bio-systems Inc. for up to 50 mill USD

WaferGen, Inc. sells an analyzer and reagent kits for single cell research, based on real-time PCR. The system is useful for the analysis of trace amount of DNA in specimens from pharmaceutical companies or for clinical testing labs. The acquisition will be done by the US subsidiary Takara Bio USA Holdings.

Takara Bio news release, May 13, 2016

Most popular posts:

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny